Literature DB >> 28424003

Phenotypic Heterogeneity in a Congenital Disorder of Glycosylation Caused by Mutations in STT3A.

Arunabha Ghosh1,2, Jill Urquhart3, Sarah Daly3, Anne Ferguson4, Diana Scotcher3, Andrew A M Morris1, Jill Clayton-Smith3,5.   

Abstract

STT3A encodes the catalytic subunit of the oligosaccharyltransferase complex. A congenital disorder of glycosylation caused by mutations in STT3A has only been reported in one family to date, associated with a Type I congenital disorder of glycosylation pattern of transferrin glycoforms. The authors describe a further 5 related individuals with a likely pathogenic variant in STT3A, 2 of whom also had variants in TUSC3. Common phenotypic features in all symptomatic individuals include developmental delay, intellectual disability, with absent speech and seizures. Two individuals also developed episodic hypothermia and altered consciousness. The family were investigated by autozygosity mapping, which revealed both a homozygous region containing STT3A and, in addition, a homozygous deletion of TUSC3 in one child. A likely pathogenic variant in STT3A was confirmed on Sanger sequencing of all affected individuals: the authors discuss the molecular findings in detail and further delineate the clinical phenotype of this rare disorder.

Entities:  

Keywords:  CDG; STT3A-CDG; TUSC3; episodic hypothermia; stereotypic behavior

Mesh:

Substances:

Year:  2017        PMID: 28424003     DOI: 10.1177/0883073817696816

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings.

Authors:  Matthew P Wilson; Alejandro Garanto; Filippo Pinto E Vairo; Bobby G Ng; Wasantha K Ranatunga; Marina Ventouratou; Melissa Baerenfaenger; Karin Huijben; Christian Thiel; Angel Ashikov; Liesbeth Keldermans; Erika Souche; Sandrine Vuillaumier-Barrot; Thierry Dupré; Helen Michelakakis; Agata Fiumara; James Pitt; Susan M White; Sze Chern Lim; Lyndon Gallacher; Heidi Peters; Daisy Rymen; Peter Witters; Antonia Ribes; Blai Morales-Romero; Agustí Rodríguez-Palmero; Diana Ballhausen; Pascale de Lonlay; Rita Barone; Mirian C H Janssen; Jaak Jaeken; Hudson H Freeze; Gert Matthijs; Eva Morava; Dirk J Lefeber
Journal:  Am J Hum Genet       Date:  2021-10-14       Impact factor: 11.025

2.  Factor VIII and vWF deficiency in STT3A-CDG.

Authors:  Irene J Chang; Heather M Byers; Bobby G Ng; John Lawrence Merritt; Reid Gilmore; Shiteshu Shrimal; Wei Wei; Yuan Zhang; Amanda B Blair; Hudson H Freeze; Bin Zhang; Christina Lam
Journal:  J Inherit Metab Dis       Date:  2019-01-30       Impact factor: 4.982

3.  Quantitative glycoproteomics reveals new classes of STT3A- and STT3B-dependent N-glycosylation sites.

Authors:  Natalia A Cherepanova; Sergey V Venev; John D Leszyk; Scott A Shaffer; Reid Gilmore
Journal:  J Cell Biol       Date:  2019-07-11       Impact factor: 10.539

4.  DC2 and KCP2 mediate the interaction between the oligosaccharyltransferase and the ER translocon.

Authors:  Shiteshu Shrimal; Natalia A Cherepanova; Reid Gilmore
Journal:  J Cell Biol       Date:  2017-08-31       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.